Firefly Neuroscience, Inc.
AIFF
$2.66
$0.0110.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 595.35% | -18.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 595.35% | -18.87% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 537.21% | -18.87% | |||
| SG&A Expenses | -12.47% | -17.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.30% | -19.39% | |||
| Operating Income | 20.87% | 19.40% | |||
| Income Before Tax | 85.85% | -241.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 85.82% | -241.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 85.82% | -241.61% | |||
| EBIT | 20.87% | 19.40% | |||
| EBITDA | 20.14% | 20.02% | |||
| EPS Basic | 91.69% | -300.44% | |||
| Normalized Basic EPS | 88.89% | -290.19% | |||
| EPS Diluted | 91.69% | -300.44% | |||
| Normalized Diluted EPS | 88.89% | -290.19% | |||
| Average Basic Shares Outstanding | 27.23% | 14.41% | |||
| Average Diluted Shares Outstanding | 27.23% | 14.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||